Skip to main content
Quest Diagnostics

Quest Diagnostics Advocacy Efforts to Address ASH Clinical Decision Limits for Ferritin for the Diagnosis of Iron Deficiency

ASH Iron Deficiency Summit Meeting 2026

American Society of Hematology

June 7,  2026

Oral presentation: Quest Diagnostics Advocacy Efforts to Address ASH Clinical Decision Limits for  Ferritin for the Diagnosis of Iron Deficiency

Authors: Edward C.C. Wong

Medical Specialty: Coagulation, Hematology, Cardiovascular

Related content

Publication
Ferritin Reference Intervals in a Population of Working-Age Adults Without Anemia
Publication
Large-scale retrospective analyses of the effect of iron deficiency anemia on hemoglobin A1c concentrations
Conference Presentation
Ferritin Reference Ranges in an Adult Population of Working-age Adults Without Anemia
Cardiovascular Diseases
Development of Trimester-Specific Reference Intervals for Evaluation of Nutritionally Related Anemia During Pregnancy

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.